PwC's Next in Health podcast artwork
Health & Fitness

PwC's Next in Health

by PwC's Health Industries
Claiming needs an RSS feed. Contact us.

Not on the Germany charts we track today.

If you like PwC's Next in Health, try…

Latest episodes

Show 7 more episodesShow fewer episodes
  • US Pharma Deals Midyear Outlook 2026: Why Dealmakers Are Leaning Into Growth

    June 24, 2026 · 14 min

    Glenn Hunzinger, PwC's US Health Industries Leader, speaks with Dan Farrell, PwC's Health Services Deals Leader, about the forces shaping health services dealmaking in 2026. Despite ongoing reimbursement uncertainty, rising medical costs…

  • What to Watch in US Health Policy Before the 2026 Midterms

    May 4, 2026 · 18 min

    As the 2026 midterm elections approach, healthcare leaders are asking whether this is just another policy cycle or a more pivotal moment in an increasingly complex and fragmented landscape. In this episode of PwC’s Next in Health, Glenn…

  • Strategies for accessing funding and managing risk in rural health transformation

    March 17, 2026 · 20 min

    With $50 billion flowing through the Rural Health Transformation Program (RHTP), healthcare leaders are questioning whether this marks short term stabilization or a real opportunity to redesign rural care. In this episode of PwC’s Next in…

  • 2026 Healthcare Investment Trends

    February 9, 2026 · 24 min

    From the JPM Healthcare Conference in San Francisco, Glenn Hunzinger, PwC’s Health Industries Leader, speaks with Jeremy Gelber, Partner at Vitruvian Partners, and Claire Love, Principal in PwC’s Deals Strategy practice to explore where…

  • Where will growth emerge in health over the next 10 years?

    January 29, 2026 · 20 min

    From the JPM Healthcare Conference in San Francisco, Glenn Hunzinger brings together Sunil Patel of Merck and Sumit Khedekar of Citigroup for a conversation about where growth in the pharmaceutical and biotech industry is headed over the…

  • Deals Outlook 2026: What’s ahead for medtech

    January 7, 2026 · 9 min

    Join Glenn Hunzinger and James Woods as they discuss what to expect for medtech dealmaking in 2026, including why buyers are poised to return, how technology is reshaping portfolios, and where investors are focusing to drive future…

  • Deals Outlook 2026: What’s ahead for health services

    December 19, 2025 · 9 min

    Join Glenn Hunzinger and Dan Farrell as they discuss why 2026 could mark a rebound year for health services dealmaking—driven by higher-quality assets, improving market conditions, and the growing role of technology and AI. They explore…

Full episode archive on Apple Podcasts →

About the show

Hosted by Glenn Hunzinger, US Health Industries Leader, the Next in Health podcast series offers insights on the most important issues facing pharma, medtech, and healthcare. PwC business leaders discuss the latest trends and their impact on health industries, whether it is policy, AI, innovation, care delivery, business model reinvention, or bold moves shaping the future. If it is happening in health industries, we are talking about it.